Inventor · disambiguated record
Habib Fakhrai
Also filed as: FAKHRAI HABIB
7 granted patents·8 pending applications·152 citations·filing 1994–2013
87Inventor score
Top patents by PatentIndex Score
15 records- 0188US7740837B2Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cellsNOVARX·Filed 2006·Granted Jun 22, 2010·8 cites·16 claims
- 0284US5772995ACompositions and methods for enhanced tumor cell immunity in vivoSIDNEY KIMMEL CANCER CT·Filed 1994·Granted Jun 30, 1998·50 cites·2 claims
- 0383US7101543B2Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cellsNOVARX·Filed 2002·Granted Sep 5, 2006·18 cites·30 claims
- 0480US6447769B1Compositions and methods for enhanced tumor cell immunity in vivoSIDNEY KIMMEL CANCER CT·Filed 2000·Granted Sep 10, 2002·5 cites·22 claims
- 0574US8293252B2Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilizationFAKHRAI HABIB·Filed 2007·Granted Oct 23, 2012·4 cites·16 claims
- 0670US6120763ACompositions and methods for enhanced tumor cell immunity in vivoSIDNEY KIMMEL CANCER CT·Filed 1997·Granted Sep 19, 2000·26 cites·10 claims
- 0769US5681562ALymphokine gene therapy of cancerSIDNEY KIMMEL CANCER CT·Filed 1994·Granted Oct 28, 1997·41 cites·24 claims
- 0847US2014194463A1Compositions for treatment of cancerNOVARX CORP·Filed 2013·Application pending·0 cites
- 0947US2014194429A1Compositions for treatment of cancerNOVARX CORP·Filed 2013·Application pending·0 cites
- 1046US2013064856A1Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilizationNOVARX CORP·Filed 2012·Application pending·0 cites
- 1138US2015037357A1Immune stimulation/metabolic inhibition as antitumor therapyNOVARX CORP·Filed 2012·Application pending·0 cites
- 1235US2014194507A1Compositions for treatment of cancerNOVARX CORP·Filed 2013·Application pending·0 cites
- 1335US2014194478A1Compositions for treatment of cancerNOVARX CORP·Filed 2013·Application pending·0 cites
- 1435US2014194465A1Compositions for treatment of cancerNOVARX CORP·Filed 2013·Application pending·0 cites
- 1533US2014248297A1Predictors of response to immunotherapyNOVARX CORP·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →